HMGA1 and vimentin are associated with unfavorable prognosis in glioma
(A) Expression level of HMGA1 in glioma with different IDH status in CGGA cohort was examined. (B) Expression level of HMGA1 in glioma with different 1p/19q status in CGGA cohort was examined. (C) Expression level of vimentin in glioma with different IDH status in CGGA cohort was examined. (D) Expression level of vimentin in glioma with different 1p/19q status in CGGA cohort was examined. (E–G) HMGA1 was associated with an unfavorable prognosis in Nanfang Hospital, CGGA, and TCGA cohorts. (H–J) Vimentin was associated with an unfavorable prognosis in Nanfang Hospital, CGGA, and TCGA cohorts.